Recombinant human interleukin 5 is a selective activator of human eosinophil function.
Open Access
- 1 January 1988
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 167 (1), 219-224
- https://doi.org/10.1084/jem.167.1.219
Abstract
Human rIL-5 was found to selectively stimulate morphological changes and the function of human eosinophils. This molecule is thus a prime candidate for the selective eosinophilia and eosinophil activation seen in disease.Keywords
This publication has 20 references indexed in Scilit:
- Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae.Proceedings of the National Academy of Sciences, 1986
- BIOLOGIC PROPERTIES INVITRO OF A RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR1986
- The kinetics of chemotactic peptide-induced change in F-actin content, F-actin distribution, and the shape of neutrophils.The Journal of cell biology, 1985
- The pathogenesis of eosinophilic endomyocardial disease in patients with carcinomas of the lungHeart and Vessels, 1985
- Large cell carcinoma of the lung associated with marked eosinophilia. A case reportCancer, 1984
- Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors.The Journal of Immunology, 1983
- Comparison of Human Eosinophils from Normals and Patients with EosinophiliaJournal of Clinical Investigation, 1980
- Enhanced Helminthotoxic Capacity of Eosinophils from Patients with EosinophiliaNew England Journal of Medicine, 1980
- The Association of Eosinophilia with Lymphoblastic Leukaemia or Lymphoma: a Study of Seven PatientsBritish Journal of Haematology, 1980
- A New Method for the Purification of Human Eosinophils and Neutrophils, and a Comparison of the Ability of These Cells to Damage Schistosomula of Schistosoma MansoniThe Journal of Immunology, 1979